Insulet (PODD) Total Current Liabilities (2010 - 2026)
Insulet's (PODD) quarterly Total Current Liabilities came in at $744.2 million in Q2 2026, down 26.32% on a YoY basis from $1.0 billion in Q2 2025, and up 8.25% quarter-over-quarter from $687.5 million in Q1 2026.
Analysis
Insulet (PODD) Total Current Liabilities (2010 - 2026) Analysis & Trends
Insulet (PODD) has reported Total Current Liabilities for 17 consecutive years, with $744.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Current Liabilities fell 26.32% year-over-year to $744.2 million; the trailing twelve-month figure through Jun 2026 stood at $744.2 million (down 26.32% YoY), and the FY2025 full-year result was $680.1 million, up 28.71% from the prior year.
- Total Current Liabilities advanced to $744.2 million in Q2 2026 per PODD's latest filing, from $687.5 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $1.0 billion in Q2 2025 and bottomed at $215.0 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $508.2 million across 5 years, with a median of $468.7 million in 2023.
- The sharpest annual moves came in 2025 and 2026: Total Current Liabilities jumped 107.84% in 2025, then slipped 26.32% in 2026.
- Over 5 years, Total Current Liabilities stood at $364.7 million in 2022, then gained by 23.72% to $451.2 million in 2023, then increased by 17.11% to $528.4 million in 2024, then increased by 28.71% to $680.1 million in 2025, then rose by 9.43% to $744.2 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $744.2 million, $687.5 million, and $680.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn | 11.80 Bn |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn | 6.68 Bn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 6.43 Bn |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn | 1.51 Bn |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn | 3.17 Bn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | 2.36 Bn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Insulet | 9.35 Bn | 8.82 Bn | 562.60 Mn | 744.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 744.20 Mn |
| Mar 31, 2026 | 687.50 Mn |
| Dec 31, 2025 | 680.10 Mn |
| Sep 30, 2025 | 647.70 Mn |
| Jun 30, 2025 | 1.01 Bn |
| Mar 31, 2025 | 520.40 Mn |
| Dec 31, 2024 | 528.40 Mn |
| Sep 30, 2024 | 506.20 Mn |
| Jun 30, 2024 | 486.00 Mn |
| Mar 31, 2024 | 432.40 Mn |
| Dec 31, 2023 | 451.20 Mn |
| Sep 30, 2023 | 451.40 Mn |
| Jun 30, 2023 | 425.00 Mn |
| Mar 31, 2023 | 383.30 Mn |
| Dec 31, 2022 | 364.70 Mn |
| Sep 30, 2022 | 334.20 Mn |
| Jun 30, 2022 | 279.30 Mn |
| Mar 31, 2022 | 215.00 Mn |
| Dec 31, 2021 | 228.80 Mn |
| Sep 30, 2021 | 228.60 Mn |